Conmed (CNMD) Cash from Investing Activities Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.13% |
| Dec 31, 2025 | -17.69% |
| Sep 30, 2025 | -143.98% |
| Jun 30, 2025 | -8.83% |
| Mar 31, 2025 | 15.19% |
| Dec 31, 2024 | 14.53% |
| Sep 30, 2024 | 6.83% |
| Jun 30, 2024 | 6.35% |
| Mar 31, 2024 | 64.66% |
| Dec 31, 2023 | -0.41% |
| Sep 30, 2023 | -3.88% |
| Jun 30, 2023 | -9.53% |
| Mar 31, 2023 | -2.37% |
| Dec 31, 2022 | -6.42% |
| Sep 30, 2022 | -39.72% |
| Jun 30, 2022 | -99.38% |
| Mar 31, 2022 | -7.37% |
| Dec 31, 2021 | 5.88% |
| Sep 30, 2021 | -33.96% |
| Jun 30, 2021 | 9.40% |
| Mar 31, 2021 | 58.71% |
| Dec 31, 2020 | 14.22% |
| Sep 30, 2020 | 56.14% |
| Jun 30, 2020 | 16.00% |
| Mar 31, 2020 | -6.32% |
| Dec 31, 2019 | -4.29% |
| Sep 30, 2019 | -0.06% |
| Jun 30, 2019 | -1.72% |
| Mar 31, 2019 | -146.37% |
| Dec 31, 2018 | 0.57% |
| Sep 30, 2018 | 3.58% |
| Jun 30, 2018 | 2.93% |
| Mar 31, 2018 | 1.74% |
| Dec 31, 2017 | 8.30% |
| Sep 30, 2017 | 5.80% |
| Jun 30, 2017 | 1.87% |
| Mar 31, 2017 | 48.39% |
| Dec 31, 2016 | 13.66% |
| Sep 30, 2016 | 20.95% |
| Jun 30, 2016 | -2.04% |
| Mar 31, 2016 | -127.91% |
| Dec 31, 2015 | -11.47% |
| Sep 30, 2015 | 0.35% |